Edwards Lifesciences director receives stock awards
LORANGER STEVEN R reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
LORANGER STEVEN R reported acquisition or exercise transactions in this Form 4 filing.
Edwards Lifesciences director Steven R. Loranger reported equity awards and updated holdings. On May 8, 2026, he received 1,064 restricted stock units and a 3,251-share restricted stock award at $0.00 per share under the 2020 Nonemployee Directors Stock Incentive Program. Both awards are scheduled to vest 100% after the earlier of one year from the grant date or the company’s next annual stockholders’ meeting. Following these grants, he directly holds 8,997 shares and indirectly holds 75,372 shares through a trust.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 4,315 shares
Grant/Award
3 txns
Insider
LORANGER STEVEN R
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 3,251 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 1,064 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 8,997 shares (Direct);
Common Stock — 75,372 shares (Indirect, By Trust)
Footnotes (2)
- F1. These restricted stock units were granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.
- F2. This restricted stock award was granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and is scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.
Key Figures
Restricted stock units granted: 1,064 shares
Restricted stock award: 3,251 shares
Grant price: $0.00 per share
+2 more
5 metrics
Restricted stock units granted
1,064 shares
Granted May 8, 2026 under 2020 Nonemployee Directors Stock Incentive Program
Restricted stock award
3,251 shares
Granted May 8, 2026 under 2020 Nonemployee Directors Stock Incentive Program
Grant price
$0.00 per share
Equity compensation awards, not open-market purchases
Direct holdings after grants
8,997 shares
Common stock directly owned after May 8, 2026 transactions
Indirect holdings by trust
75,372 shares
Common stock held indirectly through a trust as of May 8, 2026
Key Terms
restricted stock units, restricted stock award, 2020 Nonemployee Directors Stock Incentive Program
3 terms
restricted stock units financial
"These restricted stock units were granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
restricted stock award financial
"This restricted stock award was granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program."
A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.
2020 Nonemployee Directors Stock Incentive Program financial
"under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and is scheduled to become 100% vested"
FAQ
What did Edwards Lifesciences (EW) director Steven R. Loranger report in this Form 4?
Steven R. Loranger reported equity compensation awards in Edwards Lifesciences common stock. He received restricted stock units and a restricted stock award, and the filing updates his direct and indirect share holdings as of the May 8, 2026 grant date.
When do Steven R. Loranger’s new Edwards Lifesciences (EW) awards vest?
Both the 1,064 restricted stock units and the 3,251-share restricted stock award are scheduled to become 100% vested after the earlier of one year from the May 8, 2026 grant date or Edwards Lifesciences’ next annual meeting of stockholders.
Are Steven R. Loranger’s Edwards Lifesciences (EW) Form 4 transactions open-market buys or sales?
No, the Form 4 shows compensation-related acquisitions coded as “A,” not open-market trades. The grants were issued at $0.00 per share under the 2020 Nonemployee Directors Stock Incentive Program and reflect routine nonemployee director equity awards.
Under what plan were Steven R. Loranger’s Edwards Lifesciences (EW) equity awards granted?
Both the restricted stock units and the restricted stock award were granted under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program, which provides stock-based compensation to nonemployee members of the company’s board of directors.
AI-generated analysis. How Rhea-AI works. Not financial advice.
